The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...
Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...
Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.
WAUSAU, Wis. (WSAW) - In the past, being diagnosed with small-cell lung cancer seemed to be a death sentence. This type of cancer is known as one of the most aggressive and deadliest forms of cancer.
Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...
We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...
The ACS estimates that 626,140 people in the U.S. will die from cancer in 2026, amounting to about 1,720 deaths per day. Lung ...
Shame can shape how early patients get diagnosed, and how aggressively they pursue treatment, if at all. In a 2014 study, Dr.